Identifiers | |||||||||
---|---|---|---|---|---|---|---|---|---|
Symbol | Acyl-protein thioesterases (APTs) | ||||||||
Pfam | PF02230 | ||||||||
InterPro | IPR029058 | ||||||||
|
Acyl-protein thioesterases are enzymes that cleave off lipid modifications on proteins, located on the sulfur atom of cysteine residues linked via a thioester bond. [1] Acyl-protein thioesterases are part of the α/β hydrolase superfamily of proteins and have a conserved catalytic triad. [2] For that reason, acyl-protein thioesterases are also able to hydrolyze oxygen-linked ester bonds.
Acyl-protein thioesterases are involved in the depalmitoylation of proteins, meaning they cleave off palmitoyl modifications on proteins' cysteine residues. Cellular targets include trimeric G-alpha proteins, [3] ion channels [4] and GAP-43. [5] Moreover, human acyl-protein thioesterases 1 and 2 have been identified as major components in controlling the palmitoylation cycle of the oncogene Ras. [6] [7] Depalmitoylation of Ras by acyl-protein thioesterases potentially reduces Ras' affinity to endomembranes, allowing it to be palmitoylated again at the Golgi apparatus and to be directed to the plasma membrane. Acyl-protein thioesterases, therefore, are thought to correct potential mislocalization of Ras.
|
|
Currently fully validated human acyl-protein thioesterases are APT1 [8] and APT2 [9] which share 66% sequence homology. [10] Additionally there are a handful of putative acyl-protein thioesterases reported, including the ABHD17 enzyme family. [11] [12] In the lysosome, PPT1 of the palmitoyl protein thioesterase family has similar enzymatic activity as acyl-protein thioesterases.
Acyl-protein thioesterases feature 3 major structural components that determine protein function and substrate processing: 1. A conserved, classical catalytic triad to break ester and thioester bonds; [2] 2. A long hydrophobic substrate tunnel to accommodate the palmitoyl moiety, as identified in the crystal structures of human acyl-protein thioesterase 1, [2] human acyl-protein thioesterase 2 [13] and Zea mays acyl-protein thioesterase 2; [14] 3. A lid- loop that covers the catalytic site, is highly flexible and is a main factor determining the enzyme's product release rate. [14]
The involvement in controlling the localization of the oncogene Ras has made acyl-protein thioesterases potential cancer drug targets. [15] Inhibition of acyl-protein thioesterases is believed to increase mislocalization of Ras at the cell's membranes, eventually leading to a collapse of the Ras cycle. Inhibitors for acyl-protein thioesterases have been specifically targeting the hydrophobic substrate tunnel, [16] [13] the catalytic site serine [17] or both. [18]
Current approaches to study the biological activity of Acyl-protein Thioesterases include proteomics, monitoring the trafficking of microinjected fluorescent substrates, [19] [7] the use of cell-permeable substrate mimetics, [20] and cell permeable small molecule fluorescent chemical tools. [21] [22] [23] [24]
Identifiers | |||||||||
---|---|---|---|---|---|---|---|---|---|
Symbol | Acyl-protein thioesterases (APTs) | ||||||||
Pfam | PF02230 | ||||||||
InterPro | IPR029058 | ||||||||
|
Acyl-protein thioesterases are enzymes that cleave off lipid modifications on proteins, located on the sulfur atom of cysteine residues linked via a thioester bond. [1] Acyl-protein thioesterases are part of the α/β hydrolase superfamily of proteins and have a conserved catalytic triad. [2] For that reason, acyl-protein thioesterases are also able to hydrolyze oxygen-linked ester bonds.
Acyl-protein thioesterases are involved in the depalmitoylation of proteins, meaning they cleave off palmitoyl modifications on proteins' cysteine residues. Cellular targets include trimeric G-alpha proteins, [3] ion channels [4] and GAP-43. [5] Moreover, human acyl-protein thioesterases 1 and 2 have been identified as major components in controlling the palmitoylation cycle of the oncogene Ras. [6] [7] Depalmitoylation of Ras by acyl-protein thioesterases potentially reduces Ras' affinity to endomembranes, allowing it to be palmitoylated again at the Golgi apparatus and to be directed to the plasma membrane. Acyl-protein thioesterases, therefore, are thought to correct potential mislocalization of Ras.
|
|
Currently fully validated human acyl-protein thioesterases are APT1 [8] and APT2 [9] which share 66% sequence homology. [10] Additionally there are a handful of putative acyl-protein thioesterases reported, including the ABHD17 enzyme family. [11] [12] In the lysosome, PPT1 of the palmitoyl protein thioesterase family has similar enzymatic activity as acyl-protein thioesterases.
Acyl-protein thioesterases feature 3 major structural components that determine protein function and substrate processing: 1. A conserved, classical catalytic triad to break ester and thioester bonds; [2] 2. A long hydrophobic substrate tunnel to accommodate the palmitoyl moiety, as identified in the crystal structures of human acyl-protein thioesterase 1, [2] human acyl-protein thioesterase 2 [13] and Zea mays acyl-protein thioesterase 2; [14] 3. A lid- loop that covers the catalytic site, is highly flexible and is a main factor determining the enzyme's product release rate. [14]
The involvement in controlling the localization of the oncogene Ras has made acyl-protein thioesterases potential cancer drug targets. [15] Inhibition of acyl-protein thioesterases is believed to increase mislocalization of Ras at the cell's membranes, eventually leading to a collapse of the Ras cycle. Inhibitors for acyl-protein thioesterases have been specifically targeting the hydrophobic substrate tunnel, [16] [13] the catalytic site serine [17] or both. [18]
Current approaches to study the biological activity of Acyl-protein Thioesterases include proteomics, monitoring the trafficking of microinjected fluorescent substrates, [19] [7] the use of cell-permeable substrate mimetics, [20] and cell permeable small molecule fluorescent chemical tools. [21] [22] [23] [24]